The company based in Maryland(MD)reported a fellin revenue to $0.6672 milion for the year when compared to $579.78 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 9,2023 showed that its revenue is down 99.88% year-over-year.
The company reported basic earnings per share of $113.0 and diluted earnings per share of $104.0.
Supernus Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector.
Related News
